BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Teva Pharmaceutical Industries Limited (TEVA) Shares Shoot Up After Copaxone Lawsuit Victory


6/25/2012 6:29:54 AM

Teva Pharmaceutical Industries Ltd. (TEVA) jumped the most in more than 12 years after a U.S. federal district judge ruling may block generic versions of its best- selling Copaxone drug from entering the market until 2015. Shares of Petach Tikvah, Israel-based Teva surged 12 percent, the biggest gain since April 2000, to 163 shekels at the 4:30 p.m. close in Tel Aviv. The increase added 16.1 billion shekels ($4.1 billion) to Teva’s market value today. Patent claims that Teva brought against Novartis AG (NOVN)’s Sandoz unit, Mylan Inc. (MYL) (MYL), and Momenta Pharmaceuticals Inc. (MNTA) (MNTA) are infringed, valid and enforceable, U.S. District Judge Barbara Jones in Manhattan ruled. The court decision covers several patents for its multiple sclerosis medicine, the last of which deals with the manufacturing process and expires on September 2015, Teva said in a Business Wire statement on June 23.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->